Literature DB >> 16763591

The patentability of human embryonic stem cells in Europe.

Gerard Porter1, Chris Denning, Aurora Plomer, John Sinden, Paul Torremans.   

Abstract

Applicants in Europe are left with few options for the patent protection of hES cell-related technology.

Entities:  

Mesh：

Year:  2006        PMID： 16763591     DOI： 10.1038/nbt0606-653

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


  4 in total

1.  Patenting parthenotes in the US and Europe.

Authors:  Vincenzo Senatore; Christopher Thomas Scott; Vittorio Sebastiano
Journal:  Nat Biotechnol       Date:  2015-12-09       Impact factor: 54.908

2.  Embryonic stem cell patents and human dignity.

Authors:  David B Resnik
Journal:  Health Care Anal       Date:  2007-03-29

3.  Patents on Technologies of Human Tissue and Organ Regeneration from Pluripotent Human Embryonic Stem Cells.

Authors:  Xuejun H Parsons; Yang D Teng; Dennis A Moore; Evan Y Snyder
Journal:  Recent Pat Regen Med       Date:  2011

4.  Interfacing of Science, Medicine and Law: The Stem Cell Patent Controversy in the United States and the European Union.

Authors:  Sonya Davey; Neil Davey; Qian Gu; Na Xu; Rajet Vatsa; Samir Devalaraja; Paul Harris; Sreenivas Gannavaram; Raj Dave; Ananda Chakrabarty
Journal:  Front Cell Dev Biol       Date:  2015-11-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.